HighPoint Advisor Group’s Elanco Animal Health ELAN Stock Holding History

HighPoint Advisor Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$252K	Buy	+7,898	New	+$265K	0.02%	446

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighPoint Advisor Group's ELAN Position: Q3 2021 in Review

HighPoint Advisor Group opened a new position in Elanco Animal Health (ELAN) in Q3 2021: 7,898 shares worth $252K. The stake represents 0.02% of the portfolio and ranks #446 among its holdings.

452 funds tracked by Wall St. Rank hold ELAN as of Q3 2021.

HighPoint Advisor Group held 7,898 shares of Elanco Animal Health worth $252K as of Q3 2021.
Elanco Animal Health was a new HighPoint Advisor Group position in Q3 2021.
Elanco Animal Health made up 0.02% of HighPoint Advisor Group's portfolio in Q3 2021, its #446 holding.
452 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2021.

Based on HighPoint Advisor Group's 13F filing for Q3 2021, filed 15 Nov 2021.